Earnings call Aarti Industries reported Q3 FY25 revenue of INR 2,035 crore, up 14% QoQ and 8% YoY, with EBITDA rising 17% QoQ to INR 236 crore. Despite pricing headwinds, volume growth and operational ...
Which stocks including Aarti Drugs, Ixigo, General Insurance and Jubilant Pharmova will be in focus today?, On the basis of which news there will be action in the market?, What are the important ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results